Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study

Nicole Hamblett · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
cfcysticfibrosisnawithdrawal
cystic fibrosis, cf, withdrawal, eti, dornase alfa, discontinue, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 865451
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.